表紙
市場調查報告書

III期臨床試驗中醫療診斷設備的管線分析

Pipeline Analysis of Phase III Medical Diagnostic Devices: The Potential Game Changers and Growth Enablers

出版商 Frost & Sullivan 商品編碼 955660
出版日期 內容資訊 英文 51 Pages
商品交期: 最快1-2個工作天內
價格
III期臨床試驗中醫療診斷設備的管線分析 Pipeline Analysis of Phase III Medical Diagnostic Devices: The Potential Game Changers and Growth Enablers
出版日期: 2020年08月14日內容資訊: 英文 51 Pages
簡介

該報告分析了目前正在進行III期臨床試驗的醫療診斷設備的流水線:傳感器技術,芯片實驗室,基於人工智能(AI)的軟件以及診斷成像技術。購買創新產品,例如基於生物標誌物的新型診斷設備,並分析其提供的價值。

目錄

第1章執行摘要

  • 調查範圍
  • 調查方法

第2章市場概述

  • 努力實現創新思想
  • III期臨床試驗的主要工作:基於新思想的設備開發及其驗證
  • 藥物和醫療器械臨床試驗之間的主要區別
  • 遠程監控和數據收集技術可支持III期臨床試驗
  • 使用AI遠程監視測試參與者以節省時間和金錢
  • 對經過培訓的技術人員的要求是III期臨床試驗的挑戰
  • 創新醫療設備,實現及時的疾病診斷並顯著降低醫療費用

第3章與心血管有關

  • 超過一半的美國人患有一種或多種心臟病的危險因素
  • 用於診斷心臟併發症的芯片實驗室和植入技術是開發的重點
  • 人工智能數據分析是醫療器械發展的新趨勢
  • 專注於患者家用監控設備的小型化

第4章神經病學相關

  • 全世界有超過5000萬人患有癲癇病
  • 開發重點在於幫助醫生使用能夠進行準確診斷的智能算法
  • 便攜式和易於使用的家庭監控設備是未來的趨勢

第5章與腫瘤治療有關

  • 美國癌症治療費用到2020年將達到1740億美元
  • 開發基於生物標誌物的癌症診斷設備
  • 基於血液等樣本的癌症診斷設備的開發

第6章公司進入市場

  • 心血管科
  • 神經病學
  • 腫瘤治療

第7章增長機會和市場擴展策略

  • 先進的醫療設備創新
  • 通過兼併/收購策略投資創新型公司

第8章COVID-19的影響

  • 由於新的冠狀病毒感染(COVID-19)大流行,需要審查臨床試驗策略和實施計劃

第9章戰略要點

第10章主要聯繫信息

第11章後續步驟

目錄
Product Code: D9B6

Lightweight, Portable, Sensor and Artificial Intelligence-based Medical Devices Re-defining Diagnostic Scenario in Healthcare

This growth opportunity-technology (GO-TE) study identifies and analyzes some of the key developments in diagnostic medical devices across major therapeutic areas such as cardiology, neurology, and oncology. The research highlights the breakthrough diagnostic medical device technologies that are likely to be approved in the next 2-3 years. These promising technologies are set to make a significant impact in near future.

Innovations such as sensor technology, lab-on-a-chip, artificial intelligence (AI)-based software, imaging technology, and novel biomarker-based diagnosis are in late stage clinical trials. This report analyzes these innovative technologies and their unique value propositions. The report identifies key growth opportunities of technologies, strategic imperatives, and market expansion strategies for medtech companies in this space.

Table of Contents

1.0. Executive Summary

  • 1.1. Scope of Research
  • 1.2. Research Methodology
  • 1.2. Research Methodology (continued)
  • 1.3. Sensor-based Medical Devices Capable Improving Diagnosis Accuracy of Physicians Offer Huge Opportunity

2.0. Market Overview

  • 2.1. The Innovative Idea Becomes Reality by Collaborative Efforts of Fuelers, Innovation Catalysts, Regulators, and Physicians
  • 2.2. Development of Device Based on New Idea and its Validation are the Key Tasks Performed in Phase III Clinical Trial
  • 2.3. Trial Design and Organization are the Key Differences in Clinical Trials for Drugs and Medical Devices
  • 2.4. Remote Monitoring and Data Collection is the Key Driver for Phase III Diagnostic Medical Device Clinical Trials
  • 2.5. MedTech Companies can Utilize AI for Remote Monitoring of Trial Participants that will Save Costs and Time for Them
  • 2.6. The requirement for Trained Technicians is the Potential Challenge in Phase III Clinical Trials as it Increases the Overall Costs
  • 2.7. Medical Device Innovation can Significantly Reduce Healthcare Costs by Enabling Timely Disease Diagnosis

3.0. Innovation Tracker - Cardiology

  • 3.1. More than Half of the American Population have at least One Risk Factor for Heart Disease
  • 3.2. Medical Developments are Focusing on Lab-on-a-chip and Implantable Technologies for Diagnosis of Heart Complications
  • 3.3. Analysis of Collected Data Through Artificial Intelligence is the New Trend Observed in Medical Device Development
  • 3.4. MedTech Companies are Focusing on Miniaturization of the Device for Home-based Monitoring of Patients

4.0. Innovation Tracker - Neurology

  • 4.1. More than 50 Million People are Affected with Epilepsy Worldwide
  • 4.2. MedTech Companies are Focusing to Support Physicians by Offering Intelligent Algorithms for Accurate Diagnosis
  • 4.3. Portable, Easy-to-use, and Home Monitoring Medical Devices are the Upcoming Trends for Diagnostic Medical Devices in Neurology

5.0. Innovation Tracker - Oncology

  • 5.1. The US is Expected to Incur $174 Billion as Cancer Care Expenses till the End of 2020
  • 5.2. MedTech Companies are Exploring Biomarker-based Diagnosis for Cancer Diseases
  • 5.3. Medical Devices Under Development are Diagnosing Cancer Diseases based on Human Samples such as Blood

6.0. Companies to Action

  • 6.1. Companies to Action - Cardiology
  • 6.2. Companies to Action - Neurology
  • 6.3. Companies to Action - Oncology

7.0. Growth Opportunities & Market Expansion Strategies

  • 7.1. Advanced Medical Device Innovations, 2020
  • 7.1. Advanced Medical Device Innovations, 2020
  • 7.2. MedTech Companies can Offer Investment Supports to Technology Innovators Through Merger & Acquisition Strategy

8.0. Impact of COVID-19 on Clinical Trials for Medical Devices

  • 8.1. MedTech Companies may have to Reconsider its Clinical Trial Strategy and Protocol due to COVID-19 Pandemic

9.0. Strategic Imperatives

  • 9.1. The Strategic Imperative 8™
  • 9.2. The Strategic Imperative 8™
  • 9.3. The Impact of the Top Three Strategic Imperatives on the Advanced Medical Device Industry

10.0 Key Contacts

  • Key Contacts
  • Key Contacts (Continued)

11.0 Next steps

  • YOUR NEXT STEPS
  • WHY FROST, WHY NOW?
  • Legal Disclaimer